Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study (Q43806484)
Jump to navigation
Jump to search
scientific article published in December 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study |
scientific article published in December 2001 |
Statements
1 reference
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study (English)
1 reference
Appelbaum FR
1 reference
Willman CL
1 reference
List AF
1 reference
Kopecky KJ
1 reference
Head DR
1 reference
Persons DL
1 reference
Slovak ML
1 reference
Dorr R
1 reference
Karanes C
1 reference
Hynes HE
1 reference
Doroshow JH
1 reference
Shurafa M
1 reference
1 December 2001
1 reference
1 reference
98
1 reference
12
1 reference
3212-3220
1 reference
Identifiers
1 reference
1 reference